Onco-hematologia

Estudo randomizado | Daratumumabe, lenalidomida e dexametasona vs. lenalidomida e dexametasona isoladas no tratamento do mieloma múltiplo recém-diagnosticado.

28 Out, 2021 | 16:01h

Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial – The Lancet Oncology

Comentário: Overall Survival in the MAIA Trial: Daratumumab, Lenalidomide, and Dexamethasone for Newly Diagnosed Transplant-Ineligible Patients With Multiple Myeloma – The ASCO Post

---

Diretriz NCCN | Doença tromboembólica venosa associada a câncer.

21 Out, 2021 | 11:25h

Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network

Conteúdos relacionados:

ASH 2021 guidelines for prevention and treatment of venous thromboembolism in patients with cancer

Review: venous and arterial thromboembolism in patients with cancer.

Systematic Review: Does testing for cancer in people with unprovoked blood clots in the legs and lungs reduce cancer- and blood clot-related death and illness?

M-A: Extended thromboprophylaxis after hospital discharge for medically ill patients with cancer – Extended thromboprophylaxis is not associated with a reduced rate of venous thromboembolic events and is associated with increased risk of hemorrhage

Systematic review: Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy

---

Revisão sistemática | Anticoagulantes orais diretos (DOACs) podem ser benéficos para pessoas em tratamento de câncer que não têm indicação terapêutica ou profilática de anticoagulação.

14 Out, 2021 | 10:35h

Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation – Cochrane Library

---

Revisão do estado de arte | Avanços na leucemia mieloide aguda.

8 Out, 2021 | 12:08h

Advances in acute myeloid leukemia – The BMJ

 

Comentário no Twitter

Acute myeloid leukemia is an uncommon but potentially catastrophic diagnosis.

This review looks at new updates in our understanding of the biology of acute myeloid leukemia, its genetic and environmental risk factors, and new treatment options https://t.co/ugaCeYkqSH

— The BMJ (@bmj_latest) October 6, 2021

 

---

Séries do Lancet | Malignidades hematológicas em idosos.

8 Out, 2021 | 10:57h

Página principal: Haematological malignancies in older people – The Lancet Haematology

Comentário: Living longer and better with haematological malignancies: a promise for older adults too? (necessário cadastro gratuito)

A comprehensive approach to therapy of haematological malignancies in older patients (necessário cadastro gratuito)

Frailty assessment in the care of older people with haematological malignancies

Haematopoietic stem-cell transplantation in older adults: geriatric assessment, donor considerations, and optimisation of care (necessário cadastro gratuito)

Palliative care of patients with haematological malignancies: strategies to overcome difficulties via integrated care

Implementation of geriatric haematology programmes for the treatment of older people with haematological malignancies in low-resource settings

---

Podcast | Neutropenia febril.

1 Out, 2021 | 18:20h

#288 LIVE! Neutropenic Fever featuring Dr. Susan Seo – The Curbsiders

---

Diretriz | Abdome agudo em pacientes imunocomprometidos.

16 Ago, 2021 | 11:53h

Acute abdomen in the immunocompromised patient: WSES, SIS-E, WSIS, AAST, and GAIS guidelines – World Journal of Emergency Surgery

---

Resposta de anticorpos à vacinação da COVID-19 em adultos com doença hematológica maligna.

13 Ago, 2021 | 12:17h

Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease – JAMA Oncology

 

Comentário no Twitter

Honored Jama Onc has published our work. Please get yourself vaccinated for those in whom it does not work. Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease https://t.co/BXkUQGMmbO via @JAMAOnc part of @JAMANetwork

— Tom Ollila (@OllilaTom) August 11, 2021

 

---

Diretriz | Detecção laboratorial e diagnóstico inicial das gamopatias monoclonais.

6 Ago, 2021 | 11:38h

Laboratory Detection and Initial Diagnosis of Monoclonal Gammopathies: Guideline From the College of American Pathologists in Collaboration With the American Association for Clinical Chemistry and the American Society for Clinical Pathology – Archives of Pathology & Laboratory Medicine

---

Recomendações para seguimento do European PanCare para a vigilância de efeitos tardios do câncer na criança, no adolescente e no adulto jovem.

2 Ago, 2021 | 18:44h

European PanCare Follow Up Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer – European Journal of Cancer

---